Exponent (EXPO) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $90.00 from $80.00 | Jul 31, 2026 |
| UBS | Maintained | Neutral | $72.00 from $75.00 | Jul 31, 2026 |
| JP Morgan | Maintained | Overweight | $80.00 from $95.00 | May 15, 2026 |
| UBS | Maintained | Neutral | $75.00 from $85.00 | May 1, 2026 |
| JP Morgan | Maintained | Overweight | $95.00 from $100.00 | Mar 26, 2026 |
| JP Morgan | Initiated Coverage | Overweight | $100.00 | Jan 26, 2026 |
| UBS | Maintained | Neutral | $81.00 from $76.00 | Dec 15, 2025 |
| William Blair | Upgraded | Market Perform → Outperform | — | Nov 17, 2025 |
| Truist Securities | Maintained | Buy | $120.00 from $100.00 | Jul 26, 2024 |
| Truist Securities | Maintained | Buy | $100.00 from $95.00 | Apr 29, 2024 |
| Truist Securities | Maintained | Buy | $95.00 from $110.00 | Feb 2, 2024 |
| Truist Securities | Maintained | Buy | $110.00 from $120.00 | Jul 31, 2023 |
Frequently asked questions
Is EXPO a buy, sell, or hold?
Analysts covering Exponent currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on EXPO?
On Jul 31, 2026, JP Morgan maintained Exponent at Overweight with a price target of $90.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.